Literature DB >> 119639

Extrapancreatic action of sulphonylureas: effect of gliquidone on insulin and glucagon binding to rat liver plasma membranes.

W Bachmann, I Böttger, M Haslbeck, H Mehnert.   

Abstract

Gliquidone (a second generation sulphonylurea) was administered orally to normal rats 1 h before killing. Gliquidone treatment led to a decrease in plasma glucose, an increase in insulin and a diminution in glucagon concentration. Insulin binding to liver plasma membranes was enhanced by 40% in comparison with controls, whereas glucagon binding was slightly diminished. These findings indicate a greater sensitivity of liver cells to insulin during sulphonylurea treatment and support the view that sulphonylureas potentiate insulin action on the liver.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 119639     DOI: 10.1111/j.1365-2362.1979.tb00905.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors:  E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

2.  Sulphonylureas in vitro do not alter insulin binding or insulin effect on amino acid transport in rat hepatocytes.

Authors:  J Dolais-Kitabgi; F Alengrin; P Freychet
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

3.  Extrapancreatic action of the sulphonylurea gliquidone: post-receptor effect on insulin-stimulated glycogen synthesis in rat hepatocytes in primary culture.

Authors:  F Rinninger; D Kirsch; H U Häring; W Kemmler
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

4.  Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.

Authors:  W P Bieger; R Dlugosch; A Rettenmeier; H D Holler; H Bert; W Schwarz; W Fiehn; J Merkt; H Weicker
Journal:  Klin Wochenschr       Date:  1984-07-02

Review 5.  The insulin receptor concept and its relation to the treatment of diabetes.

Authors:  G M Ward
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

6.  Increased dose-response relationship of liver plasma membrane adenylate cyclase to glucagon stimulation in diabetic rats. A possible role of the guanyl nucleotide-binding regulatory protein.

Authors:  H Allgayer; W Bachmann; K D Hepp
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.